Gut Microbiome Supplements
APAC · 2 shared keywords
Updated
Reviewed by Chandani Patel
APAC Antimicrobial Alternatives for Livestock Market Industry Trends and Forecast to 2034: Segmented by (Product, Animal, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$1.85 Bn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $1.32 Bn | — | — |
| 2025 (base) | $1.44 Bn | +$126.4 Mn | — |
| 2026 (forecast) | $1.58 Bn | +$138.5 Mn | +9.6% |
| 2027 (forecast) | $1.73 Bn | +$151.8 Mn | +20.1% |
| 2028 (forecast) | $1.90 Bn | +$166.4 Mn | +31.7% |
| 2029 (forecast) | $2.08 Bn | +$182.4 Mn | +44.3% |
| 2030 (forecast) | $2.28 Bn | +$199.9 Mn | +58.1% |
| 2031 (forecast) | $2.50 Bn | +$219.1 Mn | +73.3% |
| 2032 (forecast) | $2.74 Bn | +$240.1 Mn | +90% |
| 2033 (forecast) | $3.00 Bn | +$263.1 Mn | +108.2% |
| 2034 (forecast) | $3.29 Bn | +$288.4 Mn | +128.2% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $1.44 Bn placeholder estimate |
|---|---|
| Forecast, 2034 | $3.29 Bn placeholder estimate |
| Growth (CAGR), 2025–2034 | 9.6% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Product and animal (see all) |
| Key players | DSM-Firmenich, Novonesis, Cargill, Inc, Elanco, Phibro Animal Health (see all) |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Antimicrobial alternatives for livestock replace antibiotics in farming with probiotics, enzymes, vaccines and plant extracts.
Key segments of the antimicrobial Alternatives for Livestock market include product (Probiotics, Prebiotics and Phytogenics) and animal (Poultry, Swine and Cattle).
More pets per household, owners treating pets as family, livestock disease risks and the One Health approach linking animal and human health are driving the antimicrobial Alternatives for Livestock market.
Pet insurance, diagnostics and vaccines for emerging animal diseases give the antimicrobial Alternatives for Livestock market room to grow.
Cost-sensitive farmers, fewer vets in rural areas, rules on antibiotic use in animals and slow approvals hold back the antimicrobial Alternatives for Livestock market.
The antimicrobial Alternatives for Livestock market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
In some of the countries we cover here, medicines are approved by TGA (Australia)[1], NMPA (China)[2], Drug Office (Hong Kong)[3], CDSCO (India)[4], PMDA (Japan)[5], NPRA (Malaysia)[6], Medsafe (New Zealand)[7], FDA Philippines (Philippines)[8], HSA (Singapore)[9], Thai FDA (Thailand)[10], BPOM (Indonesia)[11], DRAP (Pakistan)[12], MFDS (South Korea)[13] and Drug Administration of Vietnam (Vietnam)[14]. In some of the countries we cover here, supplement rules come from TGA (Australia)[1], SAMR (China)[15], Centre for Food Safety (Hong Kong)[16], FSSAI (India)[17], Consumer Affairs Agency (Japan)[18], NPRA (Malaysia)[6], MPI (New Zealand)[19], FDA Philippines (Philippines)[8], HSA (Singapore)[9], Thai FDA (Thailand)[10], BPOM (Indonesia)[11], DRAP (Pakistan)[12], MFDS (South Korea)[13] and Vietnam Food Administration (Vietnam)[20].
[1] Therapeutic Goods Administration. Checked 14 Nov 2026.
[2] National Medical Products Administration. Checked 14 Nov 2026.
[3] Drug Office, Department of Health. Checked 14 Nov 2026.
[4] Central Drugs Standard Control Organisation. Checked 14 Nov 2026.
[5] Pharmaceuticals and Medical Devices Agency. Checked 14 Nov 2026.
[6] National Pharmaceutical Regulatory Agency. Checked 14 Nov 2026.
[7] Medsafe. Checked 14 Nov 2026.
[8] Food and Drug Administration Philippines. Checked 14 Nov 2026.
[9] Health Sciences Authority. Checked 14 Nov 2026.
[10] Thai Food and Drug Administration. Checked 14 Nov 2026.
[11] National Agency of Drug and Food Control (BPOM). Checked 19 Nov 2026.
[12] Drug Regulatory Authority of Pakistan (DRAP). Checked 19 Nov 2026.
[13] Ministry of Food and Drug Safety. Checked 19 Nov 2026.
[14] Drug Administration of Vietnam. Checked 19 Nov 2026.
[15] State Administration for Market Regulation. Checked 14 Nov 2026.
[16] Centre for Food Safety. Checked 14 Nov 2026.
[17] Food Safety and Standards Authority of India. Checked 14 Nov 2026.
[18] Consumer Affairs Agency. Checked 14 Nov 2026.
[19] Ministry for Primary Industries. Checked 14 Nov 2026.
[20] Vietnam Food Administration. Checked 19 Nov 2026.
Food and supplement rules, labelling and health-claim regulations govern antimicrobial Alternatives for Livestock products. Authorities such as the US FDA, EFSA and national food safety bodies set what can be sold and claimed in APAC.
What doctors and scientists are doing in Antimicrobial Alternatives for Livestock right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
From our blog
APAC · 2 shared keywords
APAC · 1 shared keyword
APAC · 1 shared keyword
APAC · 1 shared keyword
APAC · 1 shared keyword
APAC · 1 shared keyword
Pharmaceuticals · APAC
Pharmaceuticals · APAC
Medical Devices · APAC
Healthcare Services · APAC
Pharmaceuticals · APAC
Pharmaceuticals · APAC